Edwards Lifesciences (EW) Change in Acquisitions & Divestments (2009 - 2026)

Edwards Lifesciences has reported Change in Acquisitions & Divestments for 17 years, with the latest figure at $442.6 million in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 27.66% year-over-year to $442.6 million in Q2 2026; TTM through Jun 2026 was $2.5 billion, a 36.6% increase from a year earlier, with the FY2025 full-year figure at $2.8 billion, up 251.96% from the prior year.
• Change in Acquisitions & Divestments was $442.6 million for Q2 2026 at Edwards Lifesciences, down from $710.1 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $827.9 million in Q1 2025, with the low at $131.0 million in Q4 2023.
• Average Change in Acquisitions & Divestments over 5 years is $351.5 million, with a median of $221.6 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments sank 50.7% in 2023, then jumped 426.32% in 2025.
• Over 5 years, Change in Acquisitions & Divestments stood at $178.5 million in 2022, then declined by 26.61% to $131.0 million in 2023, then jumped by 99.24% to $261.0 million in 2024, then soared by 170.73% to $706.6 million in 2025, then plunged by 37.36% to $442.6 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $442.6 million (Q2 2026), $710.1 million (Q1 2026), and $706.6 million (Q4 2025), per Business Quant data.